Inaniwa Taku
Department of Accelerator and Medical Physics, National Institute of Radiological Sciences, QST.
Igaku Butsuri. 2020;40(1):23-27. doi: 10.11323/jjmp.40.1_23.
The biological effectiveness of charged-particle beams depends not only on dose but also on radiation quality. The radiation quality of charged-particle beams has been most commonly represented by the linear energy transfer (LET) in radiation biology studies. We investigated a new therapeutic technique of charged-particle therapy in which two or more ion species are delivered in one treatment session for optimizing the dose and LET distributions in a patient. We refer the therapeutic technique as an Intensity Modulated composite PArtiCle Therapy (IMPACT). Helium, carbon, oxygen and neon ions are considered as ion species for the IMPACT. To demonstrate the effectiveness of the IMPACT for simultaneous optimization of dose and LET distributions, an IMPACT plan was made for a prostate case. In accordance with the prescriptions, LETs in prostate, planning target volume (PTV), and rectum could be adjusted at 80 keV/μm, at 50 keV/μm, and below 30 keV/μm, respectively, while keeping the dose to the PTV at 2 Gy uniformly. The IMPACT enables the optimization of the dose and the LET distributions in a patient, which will maximize the potential of charged-particle therapy by expanding the therapeutic window.
带电粒子束的生物学效应不仅取决于剂量,还取决于辐射质量。在辐射生物学研究中,带电粒子束的辐射质量最常用线能量转移(LET)来表示。我们研究了一种新的带电粒子治疗技术,即在一次治疗过程中输送两种或更多种离子种类,以优化患者体内的剂量和LET分布。我们将这种治疗技术称为调强复合粒子治疗(IMPACT)。氦离子、碳离子、氧离子和氖离子被视为IMPACT的离子种类。为了证明IMPACT在同时优化剂量和LET分布方面的有效性,针对一例前列腺病例制定了IMPACT计划。根据处方,在将计划靶区(PTV)的剂量均匀保持在2 Gy的同时,前列腺、PTV和直肠中的LET可分别调整为80 keV/μm、50 keV/μm和低于30 keV/μm。IMPACT能够优化患者体内的剂量和LET分布,通过扩大治疗窗口将使带电粒子治疗的潜力最大化。